Results 181 to 190 of about 148,724 (217)
Some of the next articles are maybe not open access.

CB1 receptor inverse agonist pharmacotherapy for metabolic disorders

Drug Development Research, 2009
AbstractThe cannabinoid‐1 receptor (CB1R) has been implicated in the control of energy balance based on its anatomical localization, the interaction among the endocannabinoid system and other transmitter systems, and the appetite‐enhancing effect of tetrahydrocannabinol.
Tung M. Fong   +3 more
openaire   +1 more source

Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist

Pain, 2006
Cannabinoids act on various regions in the nervous system to modulate neuronal activity including nociception. Here, we investigated CB1 receptor expression in primary afferent neurons in the dorsal root ganglion (DRG) and the efficacy of a local (intraplantar) application of the selective CB1 agonist, 2-arachidonyl-2-chloroethylamide (ACEA), on ...
Fumimasa, Amaya   +6 more
openaire   +2 more sources

Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain

Bioorganic & Medicinal Chemistry Letters, 2012
Novel, low brain penetrant, orally bioavailable CB1 receptor agonists were designed starting from a mature lead series of potent brain penetrant CB1 receptor agonists. Increasing the calculated polar surface area was found to be a good strategy for reducing brain penetration whilst retaining drug-like properties.
Julia M, Adam   +19 more
openaire   +2 more sources

Synthesis and Characterization of Potent and Selective Agonists of the Neuronal Cannabinoid Receptor (CB1)

The Journal of Pharmacology and Experimental Therapeutics, 1999
Two subtypes of the cannabinoid receptor (CB1 and CB2) are expressed in mammalian tissues. Although selective antagonists are available for each of the subtypes, most of the available cannabinoid agonists bind to both CB1 and CB2 with similar affinities.
C J, Hillard   +8 more
openaire   +2 more sources

Recent CB1 cannabinoid receptor antagonists and inverse agonists

Drug Development Research, 2009
AbstractAntagonists or inverse agonists of the cannabinoid CB1 receptor (CB1R) reported from the 2006–2007 period are reviewed. The compounds are either variations of the archetypical cannabinoid CB1 inverse agonist rimonabant (SR141716) or are other structures less obviously related to the archetype.
openaire   +1 more source

The effects of intracerebroventricular AM‐251, a CB1‐receptor antagonist, and ACEA, a CB1‐receptor agonist, on penicillin‐induced epileptiform activity in rats

Epilepsia, 2009
SummaryPurpose: Several results support the conclusion that the cannabinoid system has a role in generation and cessation of epileptic seizures. The aim of this study was to evaluate the effects of intracerebroventricular AM‐251 [N‐(piperidin‐1‐yl)‐5‐(4‐iodophenyl)‐1‐(2,4‐dichlorophenyl)‐4‐methyl‐1H‐pyrazole‐3‐carboxamide], a CB1‐receptor antagonist ...
Kozan, Ramazan   +2 more
openaire   +3 more sources

Discovery of S-444823, a potent CB1/CB2 dual agonist as an antipruritic agent

Bioorganic & Medicinal Chemistry Letters, 2012
The optimization of a series of 3-carbamoyl 2-pyridone derivatives as CB agonists is reported. These efforts resulted in the discovery of 3-(2-(1-(cyclohexylmethyl)-2-oxo-1,2,5,6,7,8,9,10-octahydrocycloocta[b]pyridine-3-carboxamido)thiazol-4-yl)propanoic acid (21), a potent dual CB1/CB2 agonist without CNS side effects induced by CB1 receptor ...
Masahide, Odan   +11 more
openaire   +2 more sources

Rational design of Gi-biased CB1 agonist with reduced side effects

Cell
The cannabinoid receptor 1 (CB1) has emerged as a promising candidate for next-generation non-opioid therapies. However, the development of therapeutics targeting CB1 has been consistently hindered by significant adverse effects. Here, through structure-activity relationship analyses focused on biased signaling, we rationally design two Gi-biased CB1 ...
Yu-Ying Liao   +17 more
openaire   +2 more sources

Interaction of the CB1 agonist ACEA and propofol

European Journal of Anaesthesiology, 2005
P.-A. Brand   +4 more
openaire   +1 more source

SR141716A induces in rats a behavioral pattern opposite to that of CB1 receptor agonists.

Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1999
To examine the acute actions of the CB1 cannabinoid receptor antagonist SR141716A [N-piperidino-5-(4-chlorophenyl)- 1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide] on typical behavioral pattern of psychoactive cannabinoids in rats.At different time after injection the tail-flick response latency, the rectal temperature, the locomotor activity ...
COSTA, BARBARA SIMONA, Colleoni, M.
openaire   +2 more sources

Home - About - Disclaimer - Privacy